Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Haynes: B-Cell Lineage Envelope Design |
| Strategy: | Combo: Protein & vector vaccines |
| Study Type: | Phase III |
| Species: | Human |
| Stage: | Assays Completed |
| Study Start Date: | 2014-04-08 |
| Study Made Public: | 2016-10-20 |
Title
RV305 vaccine regimen boosts RV144 plasma ADCC responses
Description
CAVD 452 is an immunogenicity study to evaluate ADCC activity in specimens from RV305, the follow up and boosting study to the RV144 clinical trial.
Sign in to see full information about this study and to download study data.
Products
ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/EIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.